| 2018 | Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee
| 김효송, 라선영 |
| 2018 | Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
| 김경식, 김성훈, 김은경, 김효송, 노성훈, 라선영, 서진석, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁 |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | 김건민, 김혜련, 라선영, 손주혁 |
| 2018 | Rab25 augments cancer cell invasiveness through a beta1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin | 라선영, 정재호 |
| 2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | 김태수, 라선영, 정현철, 정희철 |
| 2018 | Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.
| 김효송, 라선영 |
| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | 김효송, 라선영, 범승훈, 윤미진, 이충근, 정민규, 정현철, 조응혁 |
| 2018 | A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy | 김승섭, 김효송, 남정모, 라선영, 박경수, 정민규, 정재호, 정현철, 채동우 |
| 2018 | Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial | 김지형, 김형일, 김효송, 노성훈, 라선영, 박형순, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정현철, 최은아, 허수진, 형우진 |
| 2018 | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | 강윤구, 라선영, 정민규, 조재용 |
| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| 김승섭, 김현기, 김효송, 라선영, 박소희, 이충근, 임준석, 정민규, 정현철, 허수진 |
| 2017 | Prevalence and prognostic implications of psychological distress in patients with gastric cancer
| 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철 |
| 2017 | Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. | 강원준, 라선영, 윤미진, 조응혁, 최영득 |
| 2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| 김지현, 김현기, 노성훈, 라선영, 박소희, 안중배, 전홍재, 정현철, 정희철, 형우진 |
| 2017 | Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma | 김경식, 김민환, 김효송, 라선영, 최영득 |
| 2017 | ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition | 김태수, 라선영, 안중배, 정현철, 정희철 |
| 2017 | Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines | 김태수, 라선영, 정현철, 정희철 |
| 2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박규현, 박준철, 배수진, 백순명, 범승훈, 손태일, 신성관, 이상길, 이용찬, 이은영, 이한나, 임준석, 정민규, 정재호, 정현철, 최윤영, 형우진 |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| 김태수, 노재경, 라선영, 박규현, 신상준, 안중배, 정현철, 정희철 |
| 2017 | Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer | 금웅섭, 김효송, 노성훈, 라선영, 윤홍인, 이용찬, 임준석, 장지석, 형우진 |
| 2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| 강석민, 김지형, 김효송, 라선영, 박형순, 범승훈, 심지영, 이충근, 정민규, 정현철, 허수진, 홍그루 |
| 2017 | Characterizing the outcomes of metastatic papillary renal cell carcinoma | 라선영 |
| 2017 | Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life | 라선영 |
| 2017 | Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma | 라선영 |
| 2017 | Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
| 라선영 |
| 2017 | Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma | 라선영 |
| 2017 | Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer | 금웅섭, 김효송, 라선영, 윤홍인, 이용찬, 임준석, 형우진 |
| 2017 | A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors | 라선영, 정현철 |
| 2017 | A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors | 김건민, 라선영, 신상준, 안중배, 정현철 |
| 2017 | PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
| 김주훈, 김태수, 라선영, 박형순, 이충근, 정현철, 허수진 |
| 2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | 김형일, 김효송, 노성훈, 라선영, 안지영, 이충근, 정민규, 정용휴, 정인경, 정재호, 정현철, 허수진, 형우진 |
| 2016 | Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium | 라선영 |
| 2016 | Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference | 라선영 |
| 2016 | p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer | 김남규, 김태일, 노재경, 라선영, 박규현, 신상준, 안중배, 이강영 |
| 2016 | PTEN Methylation Dependent Sinonasal Mucosal Melanoma
| 강버들, 노미령, 라선영, 박규현, 이상은, 이상희 |
| 2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | 김지형, 김혜련, 노성훈, 라선영, 송수경, 송승은, 이유미, 이호선 |
| 2016 | Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
| 라선영, 정현주, 조남훈, 최영득 |
| 2016 | Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival. | 노미령, 라선영, 정기양 |
| 2016 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
| 김태수, 김효송, 라선영, 박규현, 박준용, 정현철 |
| 2016 | Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
| 김경식, 김성훈, 김효송, 노성훈, 라선영, 범승훈, 서진석, 신규호, 오윤정, 이영한, 조영진, 최영득, 허혁 |
| 2016 | Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
| 김윤남, 김주훈, 라선영, 임선민 |
| 2016 | Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
| 김경식, 김성훈, 김주훈, 김효송, 노성훈, 라선영, 박규현, 서진석, 신규호, 안중배, 이영한, 최영득, 허혁 |
| 2016 | Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. | 김현기, 김형일, 김효송, 노성훈, 라선영, 윤미진, 정민규, 정재호, 정현철, 조응혁, 형우진 |
| 2016 | Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis | 김주훈, 김태수, 라선영 |
| 2016 | Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma | 김경식, 김성훈, 김효송, 노성훈, 라선영, 서진석, 신규호, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁 |
| 2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy | 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박준철, 범승훈, 손태일, 신상준, 신성관, 이상길, 이용찬, 임준석, 정민규, 정재호, 정현수, 정현철, 최윤영, 형우진 |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | 김남규, 라선영, 신상준, 안중배, 이강영, 정현철, 정희철 |
| 2016 | Cranofacial osteosarcoma: Single institutional experience in Korea | 라선영, 임승택 |
| 2016 | Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer | 김현기, 김효송, 노성훈, 라선영, 정재호 |
| 2016 | Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity
| 라선영 |
| 2016 | A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
| 김효송, 라선영 |
| 2016 | Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients | 라선영, 송수경, 이충은 |
| 2016 | Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial | 라선영 |
| 2016 | Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms | 라선영, 송수경, 이충은 |
| 2016 | A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer | 라선영 |
| 2016 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial | 라선영 |
| 2016 | ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer | 라선영 |
| 2016 | Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
| 김주훈, 김지형, 김효송, 라선영, 허수진 |
| 2016 | Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration | 금기창, 금웅섭, 김효송, 노성훈, 라선영, 이용찬, 임준석, 장지석, 형우진 |
| 2016 | Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
| 김현기, 김효송, 노성훈, 라선영, 이상길, 이용찬, 정재호, 허용민, 형우진 |
| 2016 | A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
| 권우선, 김효송, 라선영, 정현철, 허수진 |
| 2016 | Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
| 라선영 |
| 2016 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
| 라선영 |
| 2015 | PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer | 김효송, 라선영, 장향란, 정민규, 정현철 |
| 2015 | Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer | 김형일, 김효송, 노성훈, 라선영, 박형순, 정민규, 정재호, 정현철, 형우진 |
| 2015 | Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
| 김수희, 김효송, 노재경, 라선영, 신규호, 신상준, 안중배, 양우익, 유철주, 임선민, 정현철, 조용진, 한정우 |
| 2015 | Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer
| 금기창, 금웅섭, 김미선, 라선영, 이용찬, 형우진 |
| 2015 | PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity | 권우선, 김남규, 라선영, 박찬희, 신상준, 안중배, 양우익, 정현철 |
| 2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| 김정민, 라선영, 안중배, 이강영, 이명은, 이충근, 정현철 |
| 2015 | Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.
| 라선영, 박미숙, 서진석, 이영한, 임승택, 최혜진 |
| 2015 | Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
| 김수희, 김효송, 라선영, 신규호, 조용진 |
| 2015 | Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study
| 김원호, 라선영, 천재희 |
| 2015 | Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation | 노미령, 라선영, 이상희, 정기양 |
| 2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | 김기향, 김현기, 김형일, 김효송, 노성훈, 라선영, 전현정, 정민규, 정재호, 정현철, 형우진 |
| 2015 | Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer | 라선영 |
| 2015 | Caregiving burden and the quality of life of family caregivers of cancer patients: the relationship and correlates | 라선영 |
| 2015 | Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer | 라선영 |
| 2015 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study | 라선영 |
| 2015 | Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium | 라선영 |
| 2015 | Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium | 라선영 |
| 2015 | Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas | 라선영 |
| 2015 | Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10 | 라선영, 이수현 |
| 2015 | Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
| 라선영 |
| 2015 | Cutaneous Serratia marcescens infections in Korea: A retrospective analysis of 13 patients | 노미령, 라선영, 이상희, 정기양 |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| 김혜련, 김효송, 노미령, 라선영, 신상준, 안중배, 이충근, 정민규, 정현철, 최혜진, 허수진 |
| 2015 | Leiomyosarcoma: investigation of prognostic factors for risk-stratification model | 김경식, 김수희, 김현주, 김효송, 노재경, 라선영, 서진석, 신규호, 안중배, 양우익, 이영한, 조영진, 최영득 |
| 2015 | The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer | 김혜련, 노성훈, 라선영, 전홍재, 정현철, 허수진 |
| 2015 | Caregiving burden and health-promoting behaviors among the family caregivers of cancer patients | 라선영 |
| 2015 | hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness | 라선영 |
| 2015 | 골종양의 항암치료에 대한 전략
| 김효송, 라선영 |
| 2014 | Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study | 김세훈, 김효송, 노재경, 라선영, 신규호, 양우익, 이재석, 임선민, 조영진 |
| 2014 | Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: Correlation with histological microvessel density | 김영진, 라선영, 심효섭, 이혜정, 정용은, 최병욱, 허진, 홍유진 |
| 2014 | Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center Study | 김효송, 노재경, 라선영, 박경숙, 서진석, 신규호, 안중배, 양우익, 이영한, 조영진 |
| 2014 | Ifosfamide-induced Fanconi syndrome with diabetes insipidus
| 강버들, 김민환, 김한상, 김효송, 라선영, 유병우, 임아영 |
| 2014 | Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer | 노성훈, 라선영, 신유근, 정현철, 정희철 |
| 2014 | Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure
| 김지형, 노미령, 라선영, 배정민, 오병호, 이재석, 정기양 |
| 2014 | High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
| 김남규, 라선영, 신상준, 안중배, 정현철 |
| 2014 | Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane | 강버들, 남정모, 라선영, 안중배, 양우익, 임승택, 전홍재, 정현철, 정희철, 홍민희 |
| 2014 | Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma | 라선영 |
| 2014 | Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case.
| 라선영, 조성빈 |
| 2014 | Clinical Features and Treatment of Collecting Duct Carcinoma of the Kidney from the Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee
| 김효송, 라선영 |
| 2014 | Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency | 김혜련, 라선영 |
| 2014 | A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
| 라선영 |
| 2014 | Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. | 라선영 |
| 2014 | First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.
| 라선영 |
| 2014 | Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial. | 라선영 |
| 2014 | Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients.
| 라선영 |
| 2014 | Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review
| 라선영 |
| 2014 | Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
| 라선영 |
| 2014 | A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma. | 라선영 |
| 2014 | First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium.
| 라선영 |
| 2014 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | 김정민, 라선영, 박승우, 신유근, 유은정, 장향란, 정현철, 정희철 |
| 2014 | The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation.
| 라선영 |
| 2014 | The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.
| 라선영 |
| 2014 | Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.
| 라선영 |
| 2014 | Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. | 라선영 |
| 2013 | Identifying genes related to radiation resistance in oral squamous cell carcinoma cell lines | 김세헌, 라선영, 박행란, 조남훈, 최윤표 |
| 2013 | Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent | 노재경, 라선영, 신상준, 안중배, 정현철, 황지원 |
| 2013 | Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
| 김귀언, 김용배, 라선영, 정인혜, 정현철, 정희철 |
| 2013 | Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.
| 라선영 |
| 2013 | Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice | 노미령, 라선영, 정기양, 정희철 |
| 2013 | Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer | 강대용, 김대준, 김세훈, 김주항, 김혜련, 라선영, 배미경, 심효섭, 이지현, 이진구, 이창영, 임선민, 정경영, 조병철 |
| 2013 | Increased Alternative Lengthening of Telomere Phenotypes of Telomerase-negative Immortal Cells upon Trichostatin – A Treatment | 라선영, 유정은, 정아라, 정현철 |
| 2013 | Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer | 라선영 |
| 2013 | Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program | 라선영 |
| 2013 | Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
| 라선영 |
| 2013 | External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study | 라선영 |
| 2013 | Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells | 김용배, 라선영, 정현철, 정희철 |
| 2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | 김기열, 김남규, 노재경, 라선영, 신상준, 안중배, 정현철, 차인호 |
| 2013 | Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma
| 라선영 |
| 2013 | The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
| 김주항, 김혜련, 남기창, 라선영, 안정련, 이진구, 조병철, 홍윤경 |
| 2013 | Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool | 남정모, 노재경, 라선영, 양우익, 이수현, 정민규, 정현철, 정희철 |
| 2013 | Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
| 강버들, 김기열, 김찬, 노성훈, 라선영, 전홍재, 정현철, 정희철 |
| 2013 | Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum
| 김효송, 라선영, 박지수, 안중배, 양우익, 이영기, 임태섭, 정현철 |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진 |
| 2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | 김기열, 노재경, 라선영, 박찬희, 신상준, 안중배, 임선민, 정현철 |
| 2013 | Changing treatment patterns in elderly patients with resectable colon cancer | 강버들, 김건민, 김남규, 김민환, 김한상, 노재경, 라선영, 신상준, 안중배, 정현철 |
| 2013 | Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
| 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철 |
| 2013 | Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | 금웅섭, 노성훈, 라선영, 윤홍인, 이용찬, 임준석, 장지석, 형우진 |
| 2013 | Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients | 권우선, 김혜련, 김효송, 라선영, 박형순, 신상준, 안중배, 이지현, 임선민 |
| 2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | 김효송, 라선영, 신상준, 안중배, 윤상현, 이혜정 |
| 2013 | PIK3CA Mutations in Hepatocellular Carcinoma in Korea
| 라선영 |
| 2013 | Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria | 라선영 |
| 2013 | Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide | 라선영 |
| 2012 | Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry | 노재경, 라선영, 신상준, 안중배, 임선민, 정현철, 황지원 |
| 2012 | External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer
| 김기열, 김주훈, 김효송, 남정모, 라선영 |
| 2012 | Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience.
| 김남규, 김태일, 노재경, 라선영, 신상준, 안중배, 정민규, 정인경, 정현철 |
| 2012 | Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.
| 김선정, 김용배, 김한상, 라선영, 박찬희, 안중배, 정현철, 정희철 |
| 2012 | Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
| 김세규, 김세훈, 김주항, 김혜련, 라선영, 심효섭, 정경영, 조병철, 홍윤경 |
| 2012 | Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.
| 라선영 |
| 2012 | Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma. | 라선영 |
| 2012 | Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis.
| 김효송, 노재경, 라선영, 신상준, 이하영, 임승택, 한정우, 홍수정 |
| 2012 | An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy. | 라선영 |
| 2012 | A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. | 김건민, 김효송, 라선영, 정인경, 정현철 |
| 2012 | Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma. | 노미령, 라선영, 정기양, 정희철 |
| 2012 | A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
| 라선영, 정현철 |
| 2012 | A new prognostic index model using meta-analysis in early-stage epithelial ovarian cancer. | 김상운, 김성훈, 김영태, 남은지, 라선영, 박현종 |
| 2012 | Methylation status of lamin A/C in gastric cancer cell lines. | 노세원, 노재경, 라선영, 오봉경, 이원석, 정현철, 정희철 |
| 2012 | Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer. | 김남규, 라선영, 박찬희, 정현철 |
| 2012 | A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer | 노성훈, 라선영, 이성숙, 정현철, 정희철, 형우진 |
| 2012 | A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy. | 김혜련, 노재경, 라선영, 박경수, 신상준, 안중배, 이윤정, 정현철 |
| 2012 | A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy. | 김혜련, 노재경, 라선영, 신상준, 안중배, 정민규, 정현철, 정희철 |
| 2012 | Phase II study of the safety and efficacy of temsirolimus in East Asian patients with advanced renal cell carcinoma | 라선영 |
| 2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group | 노재경, 라선영, 정현철 |
| 2012 | Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. | 라선영 |
| 2012 | Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes | 라선영 |
| 2012 | Body fluid MMP-2 as a putative biomarker in metastatic breast cancer
| 김기향, 노세원, 라선영, 이하영, 정민규, 정희철 |
| 2012 | Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy
| 구자승, 김승일, 김주항, 라선영, 문용화, 박병우, 박세호, 손주혁, 이수현, 정민규, 정현철, 홍수정 |
| 2012 | Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | 금웅섭, 노성훈, 라선영, 이용찬, 이창걸, 임준석, 장지석, 형우진 |
| 2012 | EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI
| 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철 |
| 2012 | Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea
| 라선영 |
| 2011 | Brain metastases from colorectal carcinoma: prognostic factors and outcome | 노재경, 라선영, 서창옥, 신상준, 안중배, 장종희, 정민규, 홍수정 |
| 2011 | Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells | 라선영, 장현, 정현철, 정희철 |
| 2011 | Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. | 강승희, 김남규, 김한상, 노재경, 라선영, 민병소, 박찬희, 안중배, 양우익, 정현철, 정희철 |
| 2011 | Prevalence and associated factors of psychological distress among Korean cancer patients | 김건민, 김경란, 김승준, 남궁기, 라선영, 윤상현, 정현철 |
| 2011 | Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases | 김명진, 라선영, 유선국, 최진영 |
| 2011 | Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer | 라선영, 안중배 |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| 노성훈, 노재경, 라선영, 신상준, 안중배, 양우익, 임종근, 정현철, 정희철 |
| 2011 | Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer | 노성훈, 노재경, 라선영, 신상준, 정현철, 정희철 |
| 2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | 김효송, 노성훈, 라선영, 정현철, 정희철, 형우진 |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | 김기열, 김효송, 라선영, 신상준, 안중배, 정현철, 정희철, 홍민희 |
| 2011 | CD44-SLC1A2 gene fusions in gastric cancer.
| 라선영, 정현철 |
| 2011 | Treatment of recurrent hepatocellular carcinoma after liver transplantation | 김혜련, 라선영, 성진실, 이수현, 이종두, 전성하, 전재윤, 정현철, 한광협 |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| 김효송, 노성훈, 노재경, 라선영, 박형순, 신상준, 전홍재, 정현철, 정희철 |
| 2011 | Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity | 노재경, 라선영, 신규호, 신상준, 이영주, 정민규, 정재헌, 홍수정 |
| 2011 | Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.
| 강영애, 김대준, 김세규, 김세현, 김주항, 라선영, 이영주, 장준, 정민규, 조병철, 홍수정 |
| 2011 | Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy
| 노성훈, 라선영, 정재호 |
| 2011 | Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.
| 김효송, 남정모, 노성훈, 노재경, 라선영, 정현철, 정희철 |
| 2011 | A densely interconnected genome-wide network of microRNAs and oncogenic pathways revealed using gene expression signatures
| 라선영, 정현철 |
| 2011 | MMP-2 as a putative biomarker for carcinomatosis in gastric cancer | 노세원, 라선영, 박찬희, 정민규, 정현철, 정희철 |
| 2011 | Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis | 김남규, 김진수, 김혜련, 노재경, 라선영, 민병소, 신상준, 안중배 |
| 2011 | Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
| 라선영 |
| 2011 | Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. | 라선영 |
| 2011 | Systematic analyses of genes associated with radiosensitizing effect by celecoxib, a specific cyclooxygenase-2 inhibitor
| 라선영, 신유근 |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철 |
| 2010 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer
| 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철 |
| 2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | 노성훈, 라선영, 임종근, 장현, 정현철, 정희철 |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | 노성훈, 노재경, 라선영, 신상준, 안중배, 임종근, 정현철, 정희철 |
| 2010 | Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells | 라선영, 장현, 정현철, 정희철 |
| 2010 | The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites | 노성훈, 라선영, 박준용, 이성숙, 이수현, 정민규, 정현철, 정희철, 홍수정 |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | 금기창, 김남규, 김호근, 노재경, 라선영, 백승혁, 신상준, 안중배, 임준석, 정현철, 정희철, 천재희, 최혜진 |
| 2010 | Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators | 노재경, 라선영, 문용화, 신상준, 심효섭, 장현 |
| 2010 | Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design | 김찬, 노성훈, 노재경, 라선영, 문용화, 장현, 정현철, 정희철, 홍민희 |
| 2010 | A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer | 노재경, 라선영, 박경수, 신상준, 안중배, 정현철, 정희철 |
| 2010 | Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia. | 김수정, 라선영, 송재우, 이경아, 이상국, 최종락 |
| 2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | 노성훈, 노세원, 노재경, 라선영, 정민규, 정현철, 정희철 |
| 2010 | Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray | 강승희, 기동혁, 노성훈, 라선영, 이원석, 정현철, 정희철 |
| 2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | 김혜련, 노성훈, 라선영, 안정련, 이광훈, 이성숙, 전성하, 정현철, 정희철 |
| 2010 | Wernicke's encephalopathy in advanced gastric cancer
| 김건민, 김주훈, 라선영, 윤상현, 이수현, 정은석, 정희철 |
| 2010 | Green tea consumption and stomach cancer risk: a meta-analysis.
| 남정모, 라선영 |
| 2010 | The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up | 김효송, 노재경, 라선영, 문용화, 신현준, 양우익, 정민규, 정현철, 정희철, 홍수정 |
| 2010 | Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis.
| 김건민, 김기향, 김주훈, 김효송, 라선영, 박영년, 윤상현, 최준정 |
| 2010 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
| 김건민, 김기향, 김민재, 김주훈, 김찬, 김효송, 노재경, 라선영, 안중배, 윤상현, 정현철 |
| 2010 | Kidney Cancer Working Group report.
| 라선영 |
| 2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | 김혜련, 노성훈, 라선영, 안정련, 이광훈, 이성숙, 전성하, 정현철, 정희철 |
| 2009 | In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer | 김용태, 노성훈, 라선영, 이정옥, 정현철, 정희철 |
| 2009 | Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
| 권우선, 노재경, 라선영, 안중배, 유내춘, 임종근, 장현, 정현철, 정희철 |
| 2009 | Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials | 노성훈, 노재경, 라선영, 박찬희, 신상준, 안중배, 정현철, 정희철 |
| 2009 | G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern | 권우선, 노성훈, 라선영, 안중배, 정재준, 정현철, 정희철 |
| 2009 | The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer | 강욱호, 노성훈, 라선영, 송재원, 오성진, 정현철, 최승호, 형우진 |
| 2009 | Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma | 노성훈, 라선영, 송재원, 오성진, 정현철, 최승호, 형우진 |
| 2009 | Prediction of high-risk patients by genome-wide copy number alterations from remaining cancer after neoadjuvant chemotherapy and surgery. | 라선영, 양우익, 정현철, 정희철 |
| 2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | 노성훈, 노재경, 라선영, 신상준, 안중배, 임종근, 정현철, 정희철 |
| 2009 | Subtelomeric DNA methylation and telomere length in human cancer cells | 라선영, 정현철, 정희철 |
| 2009 | Prediction of recurrence of early gastric cancer after curative resection | 김기열, 김성수, 노성훈, 라선영, 오성진, 이찬주, 정현철, 최승호 |
| 2009 | Identification of significant regional genetic variations using continuous CNV values in aCGH data | 김기열, 김진, 라선영, 이귀연, 정현철, 정희철 |
| 2009 | A weighted sample size for microarray datasets that considers the variability of variance and multiplicity. | 김기열, 라선영, 정현철 |
| 2009 | Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
| 라선영 |
| 2009 | DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
| 라선영 |
| 2009 | Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. | 라선영 |
| 2009 | Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies. | 라선영 |
| 2009 | Oncogenic pathway combinations predict clinical prognosis in gastric cancer
| 라선영, 정현철 |
| 2009 | Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea
| 김찬, 김효송, 라선영, 신상준, 안정련, 안중배, 전홍재, 정현철, 홍민희 |
| 2009 | Prognosis of pN3 stage gastric cancer
| 김찬, 김혜련, 노성훈, 라선영, 안정련, 이성숙, 전홍재, 정민규, 정현철, 정희철, 형우진, 홍민희 |
| 2009 | Clinical value of ezrin expression in primary osteosarcoma
| 김찬, 김혜련, 노재경, 라선영, 안중배, 양우익, 전홍재, 홍민희, 홍수정 |
| 2009 | Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
| 김혜련, 노재경, 라선영, 박영년, 유내춘, 전성하 |
| 2009 | Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer | 권오빈, 라선영, 문용화, 양우익, 유내춘, 정재헌, 정현철, 정희철 |
| 2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | 노성훈, 노재경, 라선영, 이수현, 정재헌, 정현철, 정희철 |
| 2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| 김찬, 김혜련, 노성훈, 라선영, 안정련, 임종근, 전홍재, 정현철, 정희철, 홍민희 |
| 2009 | Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. | 라선영, 정현철, 정희철 |
| 2009 | Prognostic index reflecting genetic alteration related to disease-free time for gastric cancer patient | 라선영 |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| 라선영, 박세미, 신상준, 안중배, 이상길, 정현철, 정희철 |
| 2008 | Variation of the 3' telomeric overhang lengths in human cells | 라선영, 오봉경, 정현철, 정희철 |
| 2008 | Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer | 라선영, 정현철 |
| 2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | 금기창, 김남규, 노재경, 라선영, 백승혁, 신상준, 안중배, 전성하, 정현철, 정희철, 천재희, 최혜진 |
| 2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | 노재경, 라선영, 신상준, 안중배, 유내춘, 정현철, 정희철, 조병철, 최혜진 |
| 2008 | The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer | 노재경, 라선영, 신상준, 안중배, 정현철, 정희철, 조병철, 최혜진 |
| 2008 | A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. | 노성훈, 노재경, 라선영, 유내춘, 임종근, 정현철, 정희철 |
| 2008 | Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up.
| 노성훈, 노재경, 라선영, 문용화, 민진식, 유내춘, 정현철, 정희철 |
| 2008 | Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
| 노성훈, 노재경, 라선영, 안중배, 임종근, 전성하, 정현철, 정희철 |
| 2008 | Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions
| 김기열, 라선영, 정현철, 정희철 |
| 2008 | Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene
| 라선영, 정현철 |
| 2008 | OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation
| 라선영 |
| 2008 | SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis.
| 라선영 |
| 2008 | S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
| 노성훈, 라선영, 안중배, 양우익, 정종열, 정현철, 정희철 |
| 2008 | Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
| 노성훈, 라선영, 양우익, 오봉경, 유은정, 정현철, 정희철 |
| 2008 | Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer | 김남규, 김호근, 라선영, 민병소, 성진실, 정현철 |
| 2008 | Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
| 노성훈, 노재경, 라선영, 신상준, 임종근, 정현철, 정희철 |
| 2008 | Disease Prediction Using Ranks of Gene Expressions
| 김기열, 라선영, 정현철 |
| 2008 | Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer | 노성훈, 노재경, 라선영, 신상준, 안중배, 유내춘, 정현철, 정희철 |
| 2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | 김세현, 노재경, 라선영, 신상준, 안중배, 이혜원B, 정현철, 정희철, 조병철, 최혜진 |
| 2007 | Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute | 김병수, 노성훈, 노재경, 라선영, 문용화, 유내춘, 정현철, 정희철 |
| 2007 | Molecular basis of the differences between normal and tumor tissues of gastric cancer | 노성훈, 라선영, 신지혜, 양상화, 양우익, 정현철, 정희철 |
| 2007 | Novel and simple transformation algorithm for combining microarray data sets
| 기동혁, 김기열, 라선영, 정하진, 정현철, 정희철 |
| 2007 | Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization
| 라선영, 양우익, 이귀연, 정현철, 정희철 |
| 2007 | Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer | 라선영, 양우익, 정현철, 최연호 |
| 2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철 |
| 2007 | Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) | 노재경, 라선영, 정현철, 정희철 |
| 2007 | A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer | 노성훈, 노재경, 라선영, 정현철, 정희철 |
| 2007 | An Attempt for Combining Microarray Data Sets by Adjusting Gene Expressions
| 기동혁, 김기열, 김세현, 라선영, 정재헌, 정하진, 정현철, 정희철 |
| 2007 | A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and ...
| 김세현, 라선영, 안중배, 정재헌, 정현철, 정희철, 조남훈 |
| 2007 | Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer | 라선영, 양상화, 양우익, 정하진, 정현철, 정희철, 최연호 |
| 2007 | Whole genome analysis for liver metastasis gene signatures in colorectal cancer | 기동혁, 김남규, 라선영, 박찬희, 이귀연, 이원석, 정현철, 정희철 |
| 2007 | Integrated in silico and biological validation of the blocking effect of C(o)t-1 DNA on microarray-CGH | 김기열, 라선영, 정현철, 정희철 |
| 2007 | Entropy-based analysis of the non-linear relationship between gene expression profiles of amplified and non-amplified RNA | 라선영, 양상화, 정현철 |
| 2007 | A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation | 금기창, 김남규, 김호근, 라선영, 민병소, 백승혁, 성진실, 정현철, 표홍렬 |
| 2007 | Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters
| 노재경, 라선영, 양우익, 정현철 |
| 2007 | Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single Institute | 노성훈, 라선영, 정재호, 정현철, 정희철, 조병철, 최혜진, 형우진 |
| 2007 | The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas
| 라선영 |
| 2007 | The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation | 라선영 |
| 2007 | Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations
| 노성훈, 라선영, 박찬희, 안중배, 정현철, 정희철 |
| 2007 | An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients
| 노재경, 라선영, 양우익, 정현철, 정희철, 최연호 |
| 2007 | Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma | 김도영, 김자경, 라선영, 안상훈, 윤기태, 윤미진, 이종두, 전재윤, 한광협 |
| 2007 | Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents | 라선영, 정현철, 정희철 |
| 2007 | Gastrointestinal stromal tumor of the rectum: An analysis of seven cases | 김남규, 김호근, 라선영, 백승혁, 손승국, 이강영, 정현철, 조장환 |
| 2007 | Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia
| 라선영, 유철주 |
| 2006 | Systematic analysis of cDNA microarray-based CGH. | 라선영, 안성환, 양상화, 정현철, 정희철 |
| 2006 | Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA | 강숙희, 라선영, 조남훈, 조상호 |
| 2006 | Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports
| 김호근, 노성훈, 노재경, 라선영, 안중배, 정현철, 정희철 |
| 2006 | Significant Gene Selection Using Integrated Microarray Data Set with Batch Effect
| 김기열, 라선영, 신지혜, 정현철, 정희철 |
| 2006 | Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression
| 라선영, 정현철 |
| 2006 | Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer | 라선영, 안성환, 양우익, 정현철, 정희철 |
| 2006 | Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines | 라선영, 정현철, 정희철 |
| 2006 | 유방암의 전신적 재발로 오인된 톡소플라스마증 1예
| 김범경, 라선영, 이용원, 정현철, 정희철, 조병철 |
| 2006 | Intermediate Dose 5-Fluorouracil-Induced Encephalopathy
| 라선영, 성진실, 정현철, 정희철 |
| 2006 | A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer | 노성훈, 노재경, 라선영, 정현철, 정희철 |
| 2006 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
| 노재경, 라선영, 안중배, 유내춘, 정현철, 정희철 |
| 2005 | Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents | 노재경, 라선영, 정희철 |
| 2005 | Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis
| 라선영, 문용화, 서창옥, 양우익, 정현철, 정희철 |
| 2005 | 직장에 발생한 위장관 간질종양 7예
| 김남규, 김호근, 라선영, 백승혁, 손승국, 이강영, 정현철, 조장환, 표홍렬 |
| 2005 | Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer | 김귀언, 노재경, 라선영, 문용화, 서창옥, 손주혁, 양우익, 정현철, 정희철 |
| 2005 | 진행된 직장암에서 수술 전 화학 방사선 요법 후 전직장간막절제술의 임상적 고찰: 병리학적 T 병기와 N 병기하강에 따른 임상 결과 분석
| 김남규, 라선영, 민진식, 백승혁, 성진실, 손승국, 이강영, 정현철, 조장환 |
| 2005 | 제대혈 유래 CD34 양성세포로부터 적혈구 분화유도와 microarray를 이용한 유전자 프로파일 분석
| 김현숙, 김현옥, 라선영, 유철주 |
| 2005 | 직장암에서 전 직장간막 절제술 후 측방절제연이 예후에 미치는 영향
| 김남규, 김호근, 라선영, 백승혁, 손승국, 이강영, 정현철, 조장환 |
| 2005 | Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients | 노성훈, 라선영, 양상화, 정현철, 정희철, 형우진 |
| 2005 | Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss | 라선영, 안성환, 양상화, 정현철, 정희철, 지현정 |
| 2005 | Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells | 김양석, 라선영, 심웅호, 안성환, 양상화, 여말희, 정현철, 정희철 |
| 2005 | Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients
| 김상철, 노성훈, 라선영, 서민영, 신지현, 양상화, 정하진, 정현철, 정희철 |
| 2005 | Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray
| 김상철, 김태문, 라선영, 박찬희, 서민영, 정하진, 정현철, 조가비 |
| 2005 | Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction
| 노재경, 라선영, 심웅호, 안성환, 양상화, 여말희, 정현철, 정희철 |
| 2005 | cDNA 미세배열 비교게놈교잡법 (cDNA microarray-based comparative genomic hybridization)을 이용한 염색체 이상 질환의 최신 고속 산전 유전 진단
| 노재경, 라선영, 박용원, 박찬희, 양영호, 이귀연 |
| 2004 | Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas | 김귀언, 김주항, 노재경, 라선영, 서창옥, 양우익, 유내춘, 이상욱, 정현철, 조재호, 한지숙 |
| 2004 | Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines | 라선영, 정현철 |
| 2004 | The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. | 라선영, 박병우, 박찬희, 서민영, 안중배, 양상화, 양우익, 이귀연, 정현철 |
| 2004 | 국소 진행된 직장암의 수술 전 화학방사선 요법 치료 후 종양반응 분석: 종양체적 변화와 병리조직학적 병기하강과의 상관관계 분석
| 김남규, 라선영, 백승혁, 손승국, 이강영, 정현철, 조장환 |
| 2004 | In Silico Screening for Angiogenesis-Related Genes in Rat Astrocytes
| 라선영 |
| 2004 | Phase I and Pharmacokinetic study of the oral fluoropyrimidine S-1 on a Once-Daily-for-28-day schedule in patients with advanced malignancies
| 라선영 |
| 2004 | Statistical methods of determining a cut off value between normal and disease groups
| 라선영, 정현철 |
| 2003 | cDNA Microarray Experiment: Design Issues in Early Stage and the Need of Normalization
| 라선영, 정현철 |
| 2003 | Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray | 라선영, 양상화, 정현철 |
| 2003 | Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer
| 라선영, 정현철 |
| 2003 | Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer
| 노재경, 라선영, 손주혁 |
| 2003 | Infusional Fluorouracil, Etoposide, and Cisplatin (FEP) in Advanced and Relapsed Gastric Cancer | 노성훈, 라선영, 손주혁, 정현철, 정희철 |
| 2003 | Paclitaxel and Cisplatin Combination Chemotherapy in Pretreated Breast Cancer
| 라선영, 손주혁 |
| 2003 | A Case of Paraneoplastic Nephrotic Syndrome in a Patient with Ovarian Carcinoma
| 김용태, 김주항, 김철, 노재경, 라선영, 손주혁, 심지영, 유내춘, 정현철, 한대석 |
| 2003 | Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma | 강숙희, 라선영, 심효섭, 조남훈, 조상호, 최영득, 홍성준, 홍성희 |
| 2002 | Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. | 노성훈, 라선영, 정현철, 정희철 |
| 2002 | 동소이식을 이용한 위암의 전이모델.
| 노성훈, 노재경, 라선영, 형우진 |
| 2002 | A phase II study of gemcitiabine monotherapy in breast cancer patients refractory to anthracycline and taxane
| 라선영, 정현철 |
| 2002 | Changes of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell.
| 김준명, 라선영, 정현철 |
| 2002 | Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. | 노성훈, 라선영, 정현철, 정희철 |
| 2002 | cDNA microarray를 이용한 HPV-16 E6와 연관된 유전자의 발현 분석
| 라선영 |
| 2001 | Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects
| 라선영 |
| 2001 | Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
| 구영석, 노재경, 라선영, 민진식, 손주혁, 신규호, 신현준, 양우익, 정현철, 정희철, 한수봉 |
| 2001 | Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer | 노재경, 라선영, 안중배, 정현철, 정희철 |
| 2001 | Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. | 노성훈, 라선영, 정현철, 정희철 |
(Yonsei Health Research Network)
